EA200400475A1 - Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли - Google Patents

Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли

Info

Publication number
EA200400475A1
EA200400475A1 EA200400475A EA200400475A EA200400475A1 EA 200400475 A1 EA200400475 A1 EA 200400475A1 EA 200400475 A EA200400475 A EA 200400475A EA 200400475 A EA200400475 A EA 200400475A EA 200400475 A1 EA200400475 A1 EA 200400475A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzimidazole
treatment
application
malignant tumor
substituted derivatives
Prior art date
Application number
EA200400475A
Other languages
English (en)
Other versions
EA006802B1 (ru
Inventor
Франсуа Клерк
Франсуа Ами
Изабелль Депати
Одиль Ангуйан-Бонифас
Стефани Депре
Шанталь Карре
Манфред Реснер
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of EA200400475A1 publication Critical patent/EA200400475A1/ru
Publication of EA006802B1 publication Critical patent/EA006802B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Новые соединения бензимидазола формулы I и их применения в качестве ингибиторов циклинзависимых киназ, а также новые фармацевтические композиции, содержащие их.Отчет о международном поиске был опубликован 2003.12.11.
EA200400475A 2001-09-26 2002-09-26 Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли EA006802B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01402460A EP1298125A1 (en) 2001-09-26 2001-09-26 Substituted benzimidazole compounds and their use for the treatment of cancer
PCT/EP2002/011353 WO2003028721A2 (en) 2001-09-26 2002-09-26 Substituted benzimidazole compounds and their use for the treatment of cancer

Publications (2)

Publication Number Publication Date
EA200400475A1 true EA200400475A1 (ru) 2004-08-26
EA006802B1 EA006802B1 (ru) 2006-04-28

Family

ID=8182891

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400475A EA006802B1 (ru) 2001-09-26 2002-09-26 Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли

Country Status (35)

Country Link
US (1) US7041668B2 (ru)
EP (2) EP1298125A1 (ru)
JP (1) JP4510450B2 (ru)
KR (1) KR100891439B1 (ru)
CN (1) CN100346786C (ru)
AR (1) AR037096A1 (ru)
AT (1) ATE386517T1 (ru)
AU (1) AU2002337151B2 (ru)
BR (1) BR0212856A (ru)
CA (1) CA2461622C (ru)
CO (1) CO5570675A2 (ru)
CY (1) CY1107953T1 (ru)
DE (1) DE60225159T2 (ru)
DK (1) DK1432417T3 (ru)
EA (1) EA006802B1 (ru)
ES (1) ES2301682T3 (ru)
GT (1) GT200200190A (ru)
HK (1) HK1068551A1 (ru)
HR (1) HRPK20040293B3 (ru)
HU (1) HUP0401756A3 (ru)
IL (1) IL161059A0 (ru)
ME (1) MEP16808A (ru)
MX (1) MXPA04002042A (ru)
MY (1) MY135339A (ru)
NO (1) NO327008B1 (ru)
NZ (1) NZ531246A (ru)
PA (1) PA8555501A1 (ru)
PE (1) PE20030427A1 (ru)
PL (1) PL369527A1 (ru)
PT (1) PT1432417E (ru)
RS (1) RS50896B (ru)
SI (1) SI1432417T1 (ru)
UY (1) UY27452A1 (ru)
WO (1) WO2003028721A2 (ru)
ZA (1) ZA200401887B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011250847B2 (en) * 2003-06-23 2013-06-20 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US20070208166A1 (en) * 2003-10-24 2007-09-06 Exelixis, Inc. Tao Kinase Modulators And Method Of Use
DE102004010207A1 (de) 2004-03-02 2005-09-15 Aventis Pharma S.A. Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
FR2868421B1 (fr) * 2004-04-01 2008-08-01 Aventis Pharma Sa Nouveaux benzothiazoles et leur utilisation comme medicaments
EP1598348A1 (en) 2004-05-18 2005-11-23 Aventis Pharma Deutschland GmbH Novel pyridazinone derivatives as inhibitors of CDK2
EP1836161B1 (en) 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
UA92180C2 (en) * 2005-09-06 2010-10-11 Смиткляйн Бичам Корпорейшн Benzimidazole thiophene compounds as plk inhibitors
FR2891273B1 (fr) * 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
PL2089417T3 (pl) 2006-10-12 2015-07-31 Bhi Lp Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy
PA8792501A1 (es) 2007-08-09 2009-04-23 Sanofi Aventis Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
KR20100090769A (ko) * 2007-10-12 2010-08-17 아보트 러보러터리즈 2-((ｒ)-2-메틸피롤리딘-2-일)-1ｈ-벤즈이미다졸-4-카복스아미드 결정형 1
FR2922550B1 (fr) 2007-10-19 2009-11-27 Sanofi Aventis Nouveaux derives de 6-aryl/heteroalkyloxy benzothiazole et benzimidazole, application comme medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de cmet
FR2941951B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941950B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-o-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941952B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941949B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-o-cycloalkyl ou 6-nh-cycloalkyl- triazolopyridazine-sulfanyl)benzothiazoles et benzimidazoles preparation, application comme medicaments et utilisation comme inhibiteurs de met.
WO2011091152A1 (en) * 2010-01-22 2011-07-28 Pablo Gastaminza Inhibitors of hepatitis c virus infection
CN114469984A (zh) 2015-08-25 2022-05-13 阿尔尼拉姆医药品有限公司 用于治疗前蛋白转化酶枯草杆菌蛋白酶kexin(pcsk9)基因相关障碍的方法和组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2441201C2 (de) * 1974-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Anthelminthisch wirksame 2-Carbalkoxyamino-5(6)-phenyl-sulfonyloxy-benzimidazole und Verfahren zu ihrer Herstellung
DE2541752A1 (de) * 1975-09-19 1977-03-24 Hoechst Ag Anthelminthisch wirksame 2-carbalkoxyamino-5(6)-phenyl-sulfonyloxy- benzimidazole und verfahren zu ihrer herstellung
DE3247615A1 (de) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB9900752D0 (en) * 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders

Also Published As

Publication number Publication date
WO2003028721A3 (en) 2003-12-11
PL369527A1 (en) 2005-05-02
HK1068551A1 (en) 2005-04-29
GT200200190A (es) 2003-11-11
MEP16808A (en) 2010-06-10
HRP20040293A2 (en) 2005-06-30
MY135339A (en) 2008-03-31
KR20040048904A (ko) 2004-06-10
RS50896B (sr) 2010-08-31
DE60225159D1 (de) 2008-04-03
DK1432417T3 (da) 2008-06-16
HUP0401756A3 (en) 2005-06-28
KR100891439B1 (ko) 2009-04-03
NO20041214L (no) 2004-06-24
CA2461622C (en) 2008-12-02
US7041668B2 (en) 2006-05-09
CN100346786C (zh) 2007-11-07
NO327008B1 (no) 2009-04-06
PT1432417E (pt) 2008-05-23
WO2003028721A2 (en) 2003-04-10
NZ531246A (en) 2006-06-30
HRPK20040293B3 (en) 2007-06-30
EP1432417B1 (en) 2008-02-20
EA006802B1 (ru) 2006-04-28
CO5570675A2 (es) 2005-10-31
SI1432417T1 (sl) 2008-08-31
ES2301682T3 (es) 2008-07-01
BR0212856A (pt) 2004-09-14
ATE386517T1 (de) 2008-03-15
AR037096A1 (es) 2004-10-20
EP1432417A2 (en) 2004-06-30
YU21404A (sh) 2006-08-17
CY1107953T1 (el) 2013-09-04
JP2005504112A (ja) 2005-02-10
HUP0401756A2 (hu) 2005-01-28
AU2002337151B2 (en) 2007-04-26
CA2461622A1 (en) 2003-04-10
EP1298125A1 (en) 2003-04-02
DE60225159T2 (de) 2009-02-19
UY27452A1 (es) 2003-02-28
MXPA04002042A (es) 2004-06-07
ZA200401887B (en) 2005-05-31
US20050014811A1 (en) 2005-01-20
JP4510450B2 (ja) 2010-07-21
PE20030427A1 (es) 2003-06-20
CN1558761A (zh) 2004-12-29
IL161059A0 (en) 2004-08-31
PA8555501A1 (es) 2003-06-30

Similar Documents

Publication Publication Date Title
EA200400475A1 (ru) Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли
EA200700188A1 (ru) Производные замещенного 2-алкилхиназолинона как ингибиторы parp
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
EA200300674A1 (ru) Получение гетероциклических сульфонамидных ингибиторов бета-амилоида
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA200400073A1 (ru) Пирролопиримидины как ингибиторы протеинкиназы
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
EA200400006A1 (ru) Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
DE60214703D1 (de) Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
EA200501236A1 (ru) Аминогетероарильные соединения в качестве ингибиторов протеинкиназ
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
EA200801041A1 (ru) Ингибиторы мек и способы их применения
EA199900021A1 (ru) Бициклические гетероароматические соединения в качестве ингибиторов протеинтирозинкиназы
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200601007A1 (ru) 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
EA200300306A1 (ru) Спиропиримидин-2,4,6-трионовые ингибиторы металлопротеиназы
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
EA200301100A1 (ru) Новые фталазиноны

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU